导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -7.14% | 768/1050 |
| 近一周 | -2.61% | 850/1104 |
| 近一月 | -0.07% | 132/1103 |
| 近一季 | 6.82% | 118/1092 |
| 近半年 | -2.96% | 554/1070 |
| 近一年 | -13.61% | 790/1018 |
| 近两年 | 21.09% | 768/926 |
| 近三年 | -5.49% | 715/834 |
| 成立以来 | 41.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.16% 979/1070 |
-4.90% 790/1101 |
- - |
- - |
| 2025 | 4.29% 894/1065 |
2.74% 573/1014 |
-5.95% 978/1038 |
15.27% 735/1050 |
-6.37% 761/1065 |
| 2024 | 6.43% 381/1011 |
4.49% 116/960 |
-9.59% 852/983 |
17.74% 109/991 |
-4.30% 616/1011 |
| 2023 | -18.62% 640/952 |
5.90% 260/880 |
-13.51% 841/895 |
-4.98% 306/915 |
-6.50% 637/952 |
| 2022 | -18.10% 260/867 |
-20.99% 575/773 |
18.17% 42/806 |
-13.03% 465/845 |
0.86% 395/867 |
| 2021 | 8.90% 262/740 |
-5.86% 380/580 |
21.86% 133/659 |
-11.07% 537/704 |
6.76% 153/740 |
| 2020 | 60.17% 195/554 |
-3.74% 257/419 |
35.68% 64/466 |
8.46% 291/517 |
13.08% 247/554 |
| 2019 | 51.32% 139/410 |
29.21% 417/1146 |
0.92% 242/1228 |
9.99% 109/390 |
5.50% 332/410 |
| 2018 | -30.53% 224/349 |
- - |
-8.33% 366/990 |
-9.96% 758/1000 |
-17.57% 966/1080 |
| 2017 | 15.64% 98/285 |
- - |
- - |
- - |
- - |
| 2016 | -5.96% 49/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 汇添富新兴消费股票A VS. 东吴新产业精选股票A(580008) |